Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa Details Highly Dilutive $100M Equity Line and Selling Shareholder Resale

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$3.05
Mkt Cap
$3.758M
52W Low
$2.9
52W High
$975.003
Market data snapshot near publication time

Summary

Profusa, Inc. filed a prospectus supplement detailing a highly dilutive equity line of credit with Ascent Partners Fund LLC, potentially allowing the company to raise up to $100 million, alongside the resale of 119,611 shares by the selling stockholder.


Key Events

  • Details of Equity Line of Credit (ELOC)

    Profusa may sell up to $100 million in common stock to Ascent Partners Fund LLC over 36 months, representing extreme potential dilution relative to the company's market capitalization.

  • Selling Stockholder Resale

    Ascent Partners Fund LLC is registering 119,611 shares for resale, from which the company will not receive any proceeds. This represents a significant overhang on the stock.

  • Incorporates Recent Reverse Stock Split

    The filing confirms the 1-for-75 reverse stock split was effective February 9, 2026, adjusting all share numbers, following the 8-K filed on February 5, 2026.

  • References Nasdaq Delisting Notices

    The filing incorporates prior disclosures regarding Nasdaq non-compliance for minimum market value and bid price from September 2025, underscoring ongoing listing challenges.


Analysis

This 424B3 prospectus supplement provides critical details regarding Profusa's financing strategy, following its recent S-1 registration. The company has entered into an Equity Line of Credit (ELOC) agreement with Ascent Partners Fund LLC, which could allow Profusa to sell up to $100 million in common stock to Ascent over 36 months. This represents an extremely significant potential dilution given the company's current market capitalization. Additionally, Ascent Partners Fund LLC is registering 119,611 shares for resale, from which Profusa will not receive any proceeds. This filing also incorporates previously disclosed information about the 1-for-75 reverse stock split, effective February 9, 2026, and the Nasdaq delisting notices from September 2025, highlighting the company's distressed financial and listing status. The substantial potential dilution from the ELOC, coupled with the selling stockholder's resale, signals significant pressure on existing shareholders.

At the time of this filing, PFSA was trading at $3.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.8M. The 52-week trading range was $2.90 to $975.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
May 26, 2026, 12:35 PM EDT
Filing Type: DEF 14A
Importance Score:
9
PFSA
May 26, 2026, 11:13 AM EDT
Source: Wiseek News
Importance Score:
8
PFSA
May 26, 2026, 11:05 AM EDT
Filing Type: 8-K
Importance Score:
8
PFSA
May 18, 2026, 7:50 PM EDT
Filing Type: 424B3
Importance Score:
9
PFSA
May 18, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
9
PFSA
May 15, 2026, 4:53 PM EDT
Source: Wiseek News
Importance Score:
9
PFSA
May 15, 2026, 4:45 PM EDT
Filing Type: 10-Q
Importance Score:
9
PFSA
May 15, 2026, 8:58 AM EDT
Filing Type: 8-K
Importance Score:
8
PFSA
May 08, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
9